Human Fetus at 33 Weeks in the Womb, Lateral View (Brown Skin)

Description

A fetus of approximately 33 weeks' gestation lies in a left lateral profile, fully flexed with the spine curved, the chin toward the chest and the knees drawn up so the plantar surfaces of both feet face the viewer. The head is large relative to the trunk, with a smooth vertex, a well-formed external ear, closed eyelids and a rounded nasal profile; subcutaneous fat has begun to fill out the limbs and cheeks. The hands are held near the midline close to the insertion of the umbilical cord, a short segment of which is visible with its spiralled vessels. Surrounding the fetus is the translucent amniotic membrane, and beyond it the vascularised uterine wall with its decidual and endometrial vessels forms the outer boundary of the cavity. By 33 weeks the fetus occupies most of the uterine cavity, and the amount of amniotic fluid relative to fetal volume constrains movement into this characteristic flexed attitude, the anatomical basis of fetal lie and presentation assessment on Leopold manoeuvres and ultrasound. This stage is central to late third-trimester obstetric care: monitoring of growth velocity and estimated fetal weight, biophysical profile scoring, amniotic fluid index measurement and counselling on late preterm birth, when lung maturity and thermoregulation are still incomplete. The position of the umbilical cord relative to the limbs and trunk is also relevant to discussions of cord entanglement and Doppler assessment of umbilical artery flow. The image suits obstetric and midwifery teaching sequences that follow a single pregnancy week by week, embryology and human development lectures, antenatal class visuals and patient-facing material explaining what the baby looks like and how it lies in the final weeks. It works equally well as a publication or textbook figure on third-trimester growth, and for maternity service, app and device content where a clear, calm depiction of intrauterine life is required. Anatomical accuracy verified by SciePro's Medical Advisory Board.